Rayzebio Inc
(RYZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | ADMA | ERAS | ||
| Company | Rayzebio Inc | Adma Biologics | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.49 | 16.48 | 12.02 | ||
| High | 62.50 | 16.65 | 12.30 | ||
| Low | 62.48 | 16.20 | 11.68 | ||
| Latest | 62.49 | 16.28 | 11.95 | ||
| Change | +0.01 | -0.09 | -0.06 | ||
| % Change | +0.02% | -0.55% | -0.50% | ||
| Volume | 282,700 | 1,412,800 | 4,148,100 | ||
| 20-Day Average Volume | 318,060 | 2,030,915 | 7,140,885 | ||
| Previous Close | 62.48 | 16.37 | 12.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 17.03 | 10.34 | ||
| 20-Day Raw Stochastic | 95.83% | 19.18% | 91.59% | ||
| 20-Day Relative Strength | 86.10 | 41.70 | 79.33 | ||
| Weighted Alpha | N/A | -3.72 | +480.32 | ||
| Today's Opinion | N/A | 40% Sell | 100% Buy | ||
| Previous Opinion | N/A | 40% Sell | 100% Buy | ||
| Last Month's Opinion | N/A | 32% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -7.08% since 02/03/26 | +12.90% since 02/03/26 | ||
| Low | 62.42 on 02/16/24 | 15.79 on 02/05/26 | 10.47 on 02/04/26 | ||
| High | 62.51 on 02/22/24 | 17.67 on 02/04/26 | 12.48 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -9.30% since 01/09/26 | +76.78% since 01/09/26 | ||
| Low | 61.86 on 01/24/24 | 15.79 on 02/05/26 | 5.89 on 01/12/26 | ||
| High | 62.51 on 02/22/24 | 18.34 on 01/14/26 | 12.48 on 02/09/26 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | +10.67% since 11/10/25 | +421.83% since 11/10/25 | ||
| Low | 22.14 on 11/27/23 | 14.70 on 11/11/25 | 2.21 on 11/11/25 | ||
| High | 62.51 on 02/22/24 | 20.46 on 12/12/25 | 12.48 on 02/09/26 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | -1.45% since 08/08/25 | +753.57% since 08/08/25 | ||
| Low | 17.95 on 09/26/23 | 13.76 on 11/07/25 | 1.33 on 09/03/25 | ||
| High | 62.51 on 02/22/24 | 20.46 on 12/12/25 | 12.48 on 02/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,896,028 | 3,718,140 | ||
| Shares Outstanding, K | 59,920 | 237,998 | 309,587 | ||
| Annual Sales | 0 | 426,450,000 | 0 | ||
| Annual Net Income | -68,600,000 | 197,670,000 | -161,650,000 | ||
| Last Quarter Sales | 0 | 134,220,000 | 0 | ||
| Last Quarter Net Income | -18,190,000 | 36,430,000 | -30,610,000 | ||
| 60-Month Beta | N/A | 0.49 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | 0.16 on 11/05/25 | -0.11 on 11/12/25 | ||
| Latest Earnings Date | 03/04/24 | 03/02/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.85 | 0.00 | ||